Literatur etc.

Literaturverzeichnis

• 
• 

Details

Zuletzt aktualisiert am Samstag, 17. März 2007 13:32

Geschrieben von Dr. Steffen Rabe

Hier finden Sie die auf dieser Internetzseite zitierte Literatur.

AABY, P. BMJ 1995;311:481-5

AABY, P. CLIN EXP ALLERGY 2000;30:644-50

AABY, P.BMJ 2000;321:1-8.

HTTP://WWW.BMJ.COM/CGI/REPRINT/321/7274/1435.PDF

AAP 1991 (WENTZ & MARCUSE 1991)

ABERNATHY, R.S. FED PROC 1956; 15:580

AD HOC GROUP FOR THE STUDY OF PERTUSSIS VACCINES. LANCET 1988; 1:955-960.

AGOCS MM. INT J EPIDEMIOL 1992 OCT, 21 (5), 1007-13

ALBONICO HU. MED HYPOTHESES 1998;51(4):315-20

ALDERSLADE, R.. H.M. STATIONERY OFFICE 1981, PP. 79 - 154.

ALM, J.S. LANCET 1999 MAY 1;353(9163):1485-8

ANONYMOUS. CMAJ 1993;149:314–9.

ARDAY DR, 1980-86, AM J PUBLIC HEALTH, APR 1989, 79(4), 471-4.

ARSHI, S.. VACCINE 2004

ARZNEITELEGRAMM 1991, 9:84

ARZNEITELEGRAMM 1994; 4:39

ARZNEITELEGRAMM 1995; 5; 54

ARZNEITELEGRAMM 1997; 10; 108

ARZNEITELEGRAMM 1999; 11; 120

ARZNEITELEGRAMM 2001; 12; 122

ARZNEITELEGRAMM 2002; 3; 27

ARZNEITELEGRAMM 2004; 35; 80-8

BAER, M. LANCET 1995; 345:661

BAILY, B.V.J. IND J MED RES !980; 72 (SUPPL): 1 – 74

BARLOW, WE. N Engl J Med  2001 Aug 30;345(9):656-61

BARRIOS, C. EUR J IMMUNOL 1996; 26(7):1489-96

BARTOS, H.R. NY STATE J OF MED 1972; 72:499.

BAYLOR, NW. Vaccine, 2002, 20, S18-S23

BEALE, A.J. PROCEEDINGS OF HTE ROYAL SOCIETY OF MEDICINE 1974;67:1116-1119

BEALE AJ. FEMS MICROBIOL LET 1992, 100, 469-474

BERNARD, S. AUTISM: MED HYPOTHESES 2001 APR; 56 (4):462-71

BITNUN, A. CLIN INFECT DIS 1999 OCT;29(4):855-61

BLANCO, A. MED CLIN (BARC) 1999 MAY 1;112(15):597

BLUM, H.E.: DT. ÄRZTEBLATT 1993; 90, B: 1832-1836.

BOHUS, M. LANCET 342 (1993), 239

BOLUKBASI, O. EUR NEUROL 1999;41(4):231-2

BORCHERS AT. J INVESTIG ALLERGOL CLIN IMMUNOL 2002;12(3):155-68

BRAUN, MM. PEDIATRICS 2000 OCT;106(4):E 51

BREZIN, AP. ARCH OPHTHALMOL 1995; 113 (3): 297-300.

BREWER, J.M. J IMMUNOL 1999;163:6448-54

BRISSON, M. VACCINE 20 (2002) 2500-2507

BUCHWALD, G. IMPFEN - DAS GESCHÄFT MIT DER ANGST. MÜNCHEN 1997

BUNDESGESUNDHEITSBLATT: 2000,43:519-524

BUTTERY, J. JAMA 2004, 291, S. 1751

CARMAN, W.F. LANCET 1990; 336; 325-329

CATES, CJ. COCHRANE LIBRARY, ISSUE 4, 2003

CDC. MMWR 1985; 34:550-552

CDC. MMWR 1989; 38:101-105.

CHAKRAVARTI VS, LINGAM S; ANN OF TROP PAED, 1986, 6, 293-294

CHAPMAN T. Drugs. 2003;63(13):1407-13

CHERRY, J.D. PEDIATRICS 1988; 81 (SUPPL.):939-984.

CHERRY, J.D. WESTERN J OF MED 1989; 150:319-328

CHERRY, J.D. PEDIATRICS 1998 OCT;102(4 PT 1):909-12

CHURCH, J.A.. PEDIATRICS 1985; 75:899-900

CIZMAN, M. PED INF DIS J 1989; 8:302-308.

CLEMENS, J.D JAMA 1992; 267:673-8.

COCHI, S.L. J PED 1986; 108:887-896

CODY, C.L. PEDIATRICS 1981; 68:650-660.

COLVILLE, A. LANCET 1992; 340:786.

CONATY, S. VACCINE 2004

CREANGE, A. AUTOIMMUNITY 1999;30(3):143-6

CUSI, MG. J NEUROVIROL 1999 APR;5(2):209-14

DAIVIS RM. AM J EPIDEMIOL 1987, 126, 438-49.

DEMING, M.S. AM J OF EPIDEMIOLOGY 1992; 145:393

De SERRES G. 2003 Jun 2;21(19-20):2354-61

DIAMANTI, E. VACCIN 1998 MAY-JUN;16(9-10):940-8

DAUM, R.S. J OF PED 1989; 1114:742-747

DESTEFANO, F . PEDIATRICS 2004; 113:259-266

DGPI HANDBUCH. MÜNCHEN 2000

DI MUZIO, A. Neuromuscul Disord. 2004 Feb;14(2):175-7

DOBROSAVLJEVIC, D. J EUR ACAD DERMATOL VENEREOL 1999 JUL;13(1):59-61

DUCLOS, P. DRUG SAF 1998 DEC;19(6):435 – 54

DUVERNOY, TS. PEDIATRICS 2000 OCT;106(4):E52

DYKEN, P.R. PED NEUROLOGY 1989; 5:339-341

EHRENGUT, W. DEV BIOL STAND 1979;43:165-71

EHRENGUT W; MONATSSCHR. KINDERHEILK, 1989, 137, 398-402

EKBOM, A. LANCET 1996; 348: 515-17

EKDAHL, K.. SCAND J INFECT DIS 1998, 30(3):257-262

ENRIQUEZ, R. J Allergy Clin Immunol. 2005 Apr;115(4):737-44.

ESKOLA, J. N. ENGL. J. MED. 2001; 344: 403-9

ESPED http://www-public.rz.uni-duesseldorf.de/~esped/rahmen.html

EUROSURVEILLANCE WEEKLY HTTP://WWW.EUROSURVEILLANCE.ORG

EUVAC.NET. http://www.Euvac.net

FAROOQI, IS. THORAX 1998 NOV;53(11):927-32

FARRAR JJ. J Neurol Neurosurg Psychiatry 2000;69:292-301.

FARRINGTON, C.P. LANCET 1995; 345:567-569

FESCHAREK, R.. VACCINE 1990; 8:446-456.

FIREMAN B. Pediatr Infect Dis J. 2003 Feb;22(2):163.

FISHER, MA. ANN EPIDEMIOL 2001 JAN;11(1):13-21

FIUMARA A. J Child Neurol. 2002 Sep;17(9):700-2.

FLEDELIUS, HC. ACTA OPHTHALMOL SCAND 1999 DEC;77(6):722-4

FORSEY T. J MED MICROBIOL, 41,1994,1-2

FOURNEAU JM. MOL IMMUNOL 2004;40(14-15):1095-102

FRIEDRICH, F. ACTA VIROL 1998 JUN;42(3):187-94

FROSCH, M. DT. AERZTEBLATT 1999; 96: A-3306-8

FUJINAGA, T. A. PEDIATR INFECT DIS J 1991 MAR;10(3):204-9

FULGINITI, V.A. CURRENT  PROBLEMS IN PEDIATRICS 1976; 6:6-16.

GALE, J.L. DHSS PUBLICATION (FDA)  90-1162

GALIL, K: Pediatr. Infect. Dis. J 2002; 21:931-4

GALIL, K: N. Engl. J. Med. 2002; 347:1909-15

GBE: HTTP://WWW.GBE-BUND.DE

GEIER DA. Clin Exp Rheumatol. 2002 Nov-Dec;20(6):767-71.

GEIER MR. Clin Immunol. 2003 May;107(2):116-21.

GEIER MR. Exp Biol Med (Maywood). 2003 Jun;228(6):660-4.

GEIER, MR. pediatric 203 International Pediatrics/Vol. 18/No. 2/2003

GEIER DA. med Sci Monit 2004; 10(3): PI33-39

GHERARDI RK. Rev Neurol (Paris). 2003 Feb;159(2):162-4

GILHAM,C. BMJ, doi:10.1136/bmj.38428.521042.8F (published 22 April 2005)

GIRARD, M. Autoimmunity Reviews 2005, 4: 96-100

GODREUIL S. Presse Med. 2003 Feb 15;32(6):258-9.

GOLDMAN, GS. VACCINE 2004

GOODWIN, H. J PAEDIATR CHILD HEALTH 1999 DEC;35(6):549-52

GRASLAND, A. REV MED INTERNE 1998 FEB;19(2):134-6

GRIFFIN, M.R. JAMA 1990, 263: 1641-1645

GRIFFIN, M.R. PEDIATRICS 1991 NOV;88(5):881-5

GRITZ, K. KINDERARZT 1999; 30:10 - 11

GROTTO, I. VACCINE 1998 FEB;16(4):329-34

GRUBER, B. IMPFEN. BERN 2000

GUPTA R.K. PHARM BIOTECHNOL 1995;6:229-48

GUSTAFSON, T.L. NEJM 1987; 316:771-774.

HALSEY, N.A. PED INFECT DIS J 1993; 12: 462-465

HEININGER, U. CONSILIUM INFECTIORUM TEIL 38, FRAGE 2916, 1999.

HEININGER, U. CONSILIUM INFECTIORUM TEIL 41, FRAGE 3242, 1999

HELMKE, K. DIABETOLOGIA 1986; 29:30-33

HERNAN MA. Pharmacoepidemiol Drug Saf 2003;12:S189 – 90.

HERNAN MA. Neuology 2004;63:772-3

HERSH BS, AM J PUBLIC HEALTH 1991, 81, 360-64.

HIRAYAMA, M. REW OF INF DIS 1983; 5:495-503

HIRSCH, R.L. CLINICAL IMMUNOL AND IMMUNOPATHOL 1981; 21:341-350

HOCHMANN, M. http://www.boston.com/news/globe/health_science/articles/2005/06/21/childhood_vaccine_saves_lives_but_may_lead_to_other_infections/?page=1

HOLDINESS MR. South Med J. 2003 Jan;96(1):64-5.

HOLLINGER, F.B. GUT 1996; 38 (SUPPL); 24-30

HOLT, PG. VACCINE VOLUME 21, ISSUE 24, 28 July 2003, Pages 3432-3435

HOUGH, J.C. J OF FAMILIY PRACTICE 1979; 9:587-589 www.hpa.org.uk/infections/topics_az/mumps/data_not_age.HTm

HULL, H.F. PEDIATRICS 1985; 76: 518-523

HURWITZ, E.S. PED 1994; 94:1023-1024

HUTCHINS SS. AM J EPIDEMIOL 1990, 132, 157-68.

IMANI F. Clin Immunol. 2001 Sep;100(3):355-61.

INSTITUTE OF MEDICINE ADVERSE EVENTS ASSOCIATED WITH CHILDHOOD VACCINES. WASHINGTON, DC: NATIONAL ACADEMY PRESS, 1994

INTENSIVE IMMUNIZATION PROGRAMS. HEARINGS. US GOVERNMENT PRINTING OFFICE, 1962

IRISH MEDICAL BOARDIMB NEWS. 19 DECEMBER 2000. HTTP://WWW.IMB.IE

ISHIKAWA, T. BRAIN DEV 1999 DEC;21(8):563-5

ISODA, H. RADIAT MED 1998 MAY-JUN;16(3):179-86

JABER, L. CLINICAL PEDIATRICS 1988; 27:491-494.

JACOBSON, RM. VACCINE 2001 MAR 21;19(17-19):2428-33

JADAVJI T. Pediatr Infect Dis J. 2003 Feb;22(2):119-22.

JEFFERSON, T. HEALTH ECONOMICS 1994; 3:25-37

JEFFERSION, T. VACCINE 21 (2003) 3954 - 3960

JILG, W. DT. ÄRZTEBLATT 1996; 93, B:2435-2439

JOHNSTON, SD. POSTRGRAD MED J 1998 SEP; 74(875):541 - 2

KAGA, K. INT J PEDIATR OTORHINOLARYNGOL 1998 FEB;43(1):73-5

KAISER, R. Dtsch Arztebl 2004; 101:A 2260–2264 [Heft 33]

KALDEN JR. DMW 1992, 117, 1259

KARONGA PREVENTION TRIAL GROUP: LANCET 1996; 348: 17-24

KARVONEN M. BMJ 1999 MAY 1;318(7192):1169-72

KAWASAKI, A. J NEUROOPHTHALMOL 1998 MAR;18(1):56-9

KAYGUSUZ S. Scand J Infect Dis. 2002;34(4):314-5.

KELLER-STANISLAWSKI, B. Bundesgesundheitsblatt 2004. 47: 1151-1164

KIM-FARLEY, LANCET 1984; 2:1322-1324.

KIMMAN TG, VETERINARY QUARTERLY , AUG 1992, VOL 14(3), 110-118

KOPLAN, J.P. N ENGL J MED 1979 OCT 25;301(17):906-11

KORGER, G. KLIN WOCHENSCHRIFT 1986; 64:767-775

KOSKINIEMI, M. Lancet. 1989 Jan 7;1(8628):31-4.

KOSKINIEMI M. Eur J Pediatr. 1997 Jul;156(7):541-5.

KRIES, R. Eur J Pediatr. 2005 Feb;164(2):61-9. Epub 2004 Dec 16.

KUMMER, KR DER MERKURSTAB 1999; 6:369-375

KYLE, W.S. LANCET 1992; 339:600-601

LACSON AG. Pediatr Dev Pathol. 2002 Mar-Apr;5(2):151-8.

LASCH EE, DEV BIOL STAND, 1986, 65, 137-43.

LEE, BR. The Journal of Infectious Diseases 2004; 190:477–83

LE HELLO, C. J RHEUMATOL 1999 JAN;26(1):191-4

LEVY, DL. AM J EP 1984:120, 39 - 48

LIPSITCH, M. EMERG. INFECT. DIS. 1999; 5: 336-45

MAASS, G.. MARBURG, 1995.

MAILLEFERT, JF. RHEUMATOLOGY (OXFORD) 1999 OCT;38(10):978-83

MARGOLIS, B. J INFECT DIS 2005;192:71-78

MARKOWITZ, L.E. NEJM 1989; 320:75-81.

MARKS JS, PEDIATRICS 1978, 62, 955-60.

MARKS JS, AJPH 1987, 4, 434-38.

MARTINON-TORRES, F. REV NEUROL 1999 MAY 1-15;28(9):881-2

MATSON DO, PEDIATR INFECT DIS J, APR 1993, 12(4), 292-9

MCCRUDEN, E.A.B. J CLIN PATHOL 1996; 49; 552-555

MCEWEN, PED NURSING 1993; 19: 447 -451

MCINTOSH, E.D.G.: CURRENT OP IN PED. 1994; 6: 7-16

MCVERNON, J. BMJ 2004, 329: 655-58

MEINECKE, C.K. DER MERKURSTAB 1998; 4: 220 - 229

MERIGOU, D. ANN DERMATOL VENEREOL 1998 JUL; 125(6-7):399-403

MILLER, D.L. BR MED J (CLIN RES ED) 1981 MAY 16;282(6276):1595-9

MILLER, D. BMJ 1993, 307:1171 - 1176

MILLER E, LANCET 341, APRIL 17,1993,979-994

MILLER, C. Arch Dis Child. 2004 Dec;89(12):1145-8.

MIYAKE S No To Hattatsu. 2001 Jul;33(4):336-41.

MMWR May 15, 1998, 47(18)

MMWR: NOV. 05, 1999/48 (43); 1007

MMWR Morb Mortal Wkly Rep. 2001 Oct 5;50(39):855-6.

MMWR: 2001; NOV. 23, 2001/VOL. 50/ NO. 46

MMWR: DEC 14, 2001/VOL 50/NO 49

MMWR: VOL 53, NR. 18.

MMWR: January 16, 2004 / 53(01);8-11

MMWR: August 13, 2004 / Vol. 53 / No. 31

MMWR: Vol 54 / NO. 7

MOORE, R: BMC Family Practice (2000) 1:1; http://biomedcentral.com/1471-2296/1/1

MORFIN F. Vaccine. 2002 Feb 22;20(11-12):1541-3.

MÜHLEBACH-SPONER, M. EUR J OF PED 1995; 154:166

MÜHLHAUSER, I. DT. ÄRZTEBLATT 1996; 93: A-3280-3283

MÜSCHENBORN, S. PÄD HAUTNAH 2000, 1: 8 – 22

MUTIUS, E. SCHWEIZ MED WOCHENSCHRIFT,1998 Nov 21;128(47):1833-9.

NAGAI, T. VACCINE 2001 JAN 8;19(11-12):1353-5

NAKAMURA N. Intern Med. 2003 Feb;42(2):191-4

NEAU, D. SCAND J INFECT DIS 1998;30(2):115-8

NEUSTAEDTER, R. THE VACCINE GUIDE. BERKELEY 1996

NEUZIL, K.M. VACCINE 1997;15(5):525-32

NEWHOUSE ML. BR J PREV SOC MED 1997;31:148-53

NICHOLSON, J.K.A. J OF AIDS 1992; 5:528-537

NICHOLSON, K.G. LANCET 1998 JAN 31;351(9099):326-31

NIU, MT. ARCH PEDIATR ADOLESC MED 1999 DEC;153(12):1279-82

NOBLE, G.R. JAMA 1987; 257:1351-1356.

NOKES, D.J. LANCET 1991;338:1309-12

NOSSAL, G.J. LANCET 1997;350(9087):1316-9

OEHEN, S. SCIENCE 1991 JAN 11;251(4990): 195-8

OLDER, SA. SEMIN ARTHRITIS RHEUM 1999 DEC;29(3):131-9

OLESEN, A.B. Acta Derm Venereol 2003; 83: 445–450

ORAL POLIO VACCINE STATEMENT. EPI-INSIGHT 2001;2:4. HTTP://WWW.NDSC.IE/EPI_INSIGHT/ 0101EI.PDF

OSTERHOLM, M.R. JAMA 1988; 260:1423-1428.

PANAGIOTOPOULOS, T. BMJ 1999 CEC 4;319(7223):1462-7

PEI. PRESSEMITTEILUNG - 23. JUNI 2000

PENNESI M.. Pediatr Infect Dis J. 2002 Feb;21(2):172-3.

PETERSEN, KM. Pediatr Infect Dis J. 2004 Jul;23(7):650-655

PFAHLBERG, A. J INVESTIGATIVE DERM 119, 570 - 575

PICHICHERO ME, Pediatr Infect Dis J 1997;16:863-70.

PLESNER, AM. ACTA PAEDIATR 2000 JAN;89(1):58-63

POLLOCK, T.M. LANCET 1983; 1:753-757

PONSONBY, L. JAMA 2005, 293, NR. 4, 463

POPE, JE. J RHEUMATOL 1998 SEP;25(9):1687-93

PRICE, D. VACCINE 2004.

QUAK, T. WWW.MED.UNI-MUENCHEN.DE/FACHSCHAFT/HOMEOPATHY/ JOURIMP.HTML

RAMSAY, M.E. LANCET 2001; 357: 195-6

RATNER, A: Pediatr Infect. Dis. J. 2002; 21: 927-30

RAVEL G. TOXICOLOGY 2004;196(3)211-6

RELYVELD, E.H. VACCINE 1998 MAY-JUN;16(9-10):1016-23

RENARD, JL. PRESSE MED 1999 JUL 3 - 10;28(24):1290-2

RKI. EPID BULL III/1998 (SONDERAUSGABE).

RKI. EPID BULL 1/99, S. 1 - 4

RKI. EPID BULL 8/99, S. 49.

RKI. EPID BULL 23/99, 171 FF.

RKI. EPID. BULL 4/2000, S. 31.

RKI. EPID BULL 5/2000,  S. 60.

RKI. EPID BULL 7/2000, 49.

RKI. EPID. BULL 7/2000

RKI. EPID. BULL 7/2000, S. 215

RKI. EPID BULL 07/2001, S. 222

RKI. EPID Bull 05/2002, S. 188

RKI. Epid Bull 19/2002, S. 155 ff.

RKI. Epid Bull 24/2002

RKI. Jahrbuch 2003 UND JAHRBUCH 2004

RKI http://www.rki.de/cln_011/nn_226734/DE/Content/Infekt/EpidBull/Archiv/2005/13__05,templateId=raw,property=publicationFile.pdf/13_05

RONCHI, F. ARCH DIS CHILD 1998 MAR;78(3):273-4

RONNE T, LANCET, JAN 1985, 1-5.

ROOTH IB, AM J TROP MED HYG, NOV 1992, 47(5), 675-81.

ROSS, R.T. LANCET 1991; 337:300

ROWE, J. INFECT IMMUN 2000;68(7):3873-7

SAADOUN, D. REV MED INTERNE 2001 FEB;22(2):172-6

SACKET, D. BMJ 1996;  312:  71-2

SAKAGUCHI, M. VACCINE 1998 JUL;16(11-12):1138-40.

SCHAAD, U.B. PÄDIATRISCHE INFEKTIOLOGIE. MÜNCHEN 1997.

SCHAFFNER, W. AM J OF DIS OF CHILD 1974;127:684-688

SCHEIFELE DW. Clin Infect Dis. 2003 Apr 1;36(7):850-7. Epub 2003 Mar 18

SCHNEEWEIß, B. DT. ÄRZTEBLATT 1996; 93:A-3270-3276

SEN S. Acta Paediatr. 2001 Aug;90(8):916-20.

SEWARD, J. :JAMA 2002; 287: 606-11

SHAHEEN, S.O. LANCET 1996; 347:1792-796

SHAW, F.E. AM J OF EPID 1988; 127:337-352.

SHEIKH, A. Cochrane Library Issue 4, 2003

SILFVERDAL, SA. INT J EPIDEMIOL 1997, 26(2):443-50

SILVA, S. J NEUROIMMUN 2004, 152: 176-182

SKOWRONSKI DM. Clin Infect Dis. 2003 Mar 15;36(6):705-13.

SLACK, MH. ARCH DIS CHILD FETAL NEONATAL ED 1999 JUL;81(1)F67-8

SOOD, S.K. PEDIATRICS 1990; 85 (4 PT 2):698-704.

STEHR, K. SCHUTZIMPFUNG GEGEN PERTUSSIS. MARBURG 1985

STEWART, O. BR J OPHTHALMOL 1999 OCT;83(10):1200-1

STICKL, MONATSSCHRIFT KINDERHEILKUNDE 1984; 132, S. 493

STRAETEMANS M. COCHRANE LIBRARY, ISSUE 1, 2004

STREBEL, P.M. N ENGL J MED 1995 FEB 23;332(8):500-6

STRUVE, J. EUR J OF EPID 1996; 12:319-322

SUGIURA, A. PED INF DIS J 1991; 10:209-213.

SUTTER, R.W. LANCET 1991; 338: 715-720.

SUZUKI M. Nippon Hinyokika Gakkai Zasshi. 2002 May;93(4):577-9.

SWARTZ, T.A. AM J OF EPID 1971; 94:246-251

SWINGLER, G. COCHRANE LIBRARY, ISSUE 4, 2003

TAVADIA S. Clin Exp Dermatol. 2003 Mar;28(2):154-6.

TAYLOR, R. Nature 437, 1070 - 1071 (20 October 2005)

THOMAS, s. Lancet. 2002 Aug 31;360(9334):678-82

THOMPSON, N.P. LANCET 1995; 345:1071-1073

THYAGARAJAN, S.P. LANCET 1988; II: 764-766

TINGLE, A.J. LANCET 1996; 349:1277-1281

TIRU M. Vaccine 2000;18:2295-306.

TORALDO, R.. ACTA PAED 1992; 81:887-890

TOURBAH, A. NEUROLOGY 1999 JUL 22;53(2):396-401

TOUZE E. Neuroepidemiology. 2002 Jul-Aug;21(4):180-6

TUGWELL, B: Pediatrics 2004; 113: 455-9

UBERALL, M.A. DEV BIOL STAND 1997; 89:83-9

VADHEIM, C.M. PEDIATRICS 1993; 92:272-279.

VARGAS, MH. Respir Med. 2005 Jun 6

VAUGELADE, J. BMJ, doi:10.1136/bmj.38261.496366.82 (pub 18 Nov 2004)

VERSTRAETEN, T. Pediatrics 2003, 112(5):1039-48

VITAL C. J Peripher Nerv Syst. 2002 Sep;7(3):163-7.

VLEEMING, W. LAB ANIM 2000 OCT;34(4):399-402

WAKEFIELD, A.J. GASTROENTEROLOGY 1995; 108:911-916.

WAKEFIELD, A.J. LANCET 1998 FEB 28;351(9103):637-41

WAHLBERG, J. Ann. N.Y. Acad. Sci. 1005: 404–408 (2003).

WALY, M.. Molecular Psychiatry (2004), 1–13

WEIBEL, R.E.. JAMA 1972; 222: 805-807

WEIBEL, R.E. PEDIATRICS 1998 MAR;101(3PT1):383-7

WELDON, D. ZITIERT NACH HTTP://WWW.THINKTWICE.COM/FRAUD.HTM

WENTZ, K.R. PEDIATRICS 1991 MAR;87(3):287-97

WER http://www.who.int/wer/en/

WEST R. CANCER 1966;19:1001-7

WESTPHAL GA. Arch Toxicol. 2003 Jan;77(1):50-5. Epub 2002 Nov 06.

WHITE, W.G. J OF HYGIENE 1983; 61:283-297

WHO. DECLARATION OF ALMA ATA. GENEVE 1978

WHO. DECLARATION OF RIGA. GENEVE 1988

WHO. OTTAWA-CHARTA ZUR GESUNDHEITSFÖRDERUNG IN PRÄVENTION UND GESUNDHEITSFÖRDERUNG IM KANTON ZÜRICH 1996;2:7 - 9

WILLIAMS, J.R. EPID INFECT 1996; 116:71-89

WILLIAMS, L.K. J ALLERGY CLIN IMMUNOL 2004;1113;291-6

WIRREL E. J Pediatr. 2004 Dec;145(6):845-7.

WISE RP. JAMA 2000, 284(19): 1271–1279

WOLF, F. EUR J DERMATOL 1998 SEP;8(6); 435-6

WRAITH DC. LANCET 2003;462(9396):1659-66

WYSOKINSKA, T. VACCINE, 2004

YANAI-BERAR N. Clin Nephrol. 2002 Sep;58(3):220-3.

YAZBAK, F.E.: Regressive autism and MMR vaccination. http://www.redflagsweekly.com/yazbak/2003_nov01_6.html

YAZBAK, F. E. http://www.redflagsdaily.com/yazbak/2005_oct28.html

ZINKA, B. VACCINE 2005

ZINKE, M. KINDERARZT 1999; 30: 8

• < Zurück
• Weiter >